Quizartinib latest market price reference in 2026

Quizartinib (Quizartinib) is an oral kinase inhibitor mainly used to treat patients with FLT3-internal tandem duplication (ITD)-positive acute myeloid leukemia (AML). By targeting the activity of FLT3 tyrosine kinase, the drug inhibits the growth and spread of cancer cells and has achieved significant efficacy, especially in patient groups where traditional treatments are ineffective. Although quizartinib has achieved good therapeutic effects in the international market, its high price has also made the treatment costs for patients heavier.

In the Chinese market, the original drug of Quizartinib has not yet been approved for marketing, which makes domestic patients unable to purchase the drug directly through formal channels, and the market price of the drug is still uncertain. However, the European version of the original drug Quizartinib has been sold in some overseas markets. Its common specifications include 17.7mg 28-tablet package and 26.5mg 56-tablet package. According to current market information, the price of the European version of Quizartinib is approximately RMB 80,000 to RMB 100,000. This price may fluctuate due to factors such as exchange rate fluctuations and transportation costs. The drug is sold in some imported drug stores or through professional medical drug agents, but due to the high price, ordinary patients may face greater financial pressure.

In addition to the original drug, generic drugs of Quizartinib have also appeared in overseas markets. For example, the generic version produced by Lucius Pharmaceuticals in Laos has almost exactly the same ingredients as the original drug. Generic drugs are sold at a lower price, with a common specification of 14 tablets and a price of about 1,000 yuan, but their prices will also fluctuate due to factors such as exchange rates. Although generic drugs are more affordable, patients should still be cautious when using them to ensure that the drugs they choose come from reliable sources and meet therapeutic standards.

Keyword tags: Quizartinib,Quizartinib, market price, FLT3-ITD, acute myeloid leukemia, AML, drug import, generic drugs, price fluctuations, exchange rate

Reference materials:https://go.drugbank.com/drugs/DB12874